Funders › RI › Dr Ralph & Marian Falk Medical Research TR › 2025
Grants paid by Dr Ralph & Marian Falk Medical Research TR, tax year 2025
EIN 36-6975534 · Dallas, RI · Form 990-PF, Part XV
In tax year 2025, Dr Ralph & Marian Falk Medical Research TR (EIN 36-6975534) reported 38 grants paid totaling $8,279,791. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2025
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Case Western Reserve University Cleveland, OH | U | $355,809 | paid | IMMUNOTHERAPY FOR B CELL | 202600389349100700 |
| 2025 | Yale University - School of Medicine New Haven, CT | U | $348,252 | paid | MAKING CANCER CELLS LOOK | 202600389349100700 |
| 2025 | Indiana University Bloomington, IN | C | $340,879 | paid | PIM2 MODULATOR-MULTIPLE | 202600389349100700 |
| 2025 | Medical College of Wisconsin Milwaukee, WI | B | $334,583 | paid | PAIN THERAPY - SENSORY | 202600389349100700 |
| 2025 | Thomas Jefferson University Philadelphia, PA | B | $333,333 | paid | PROTACS FOR TARGETING BRCA | 202600389349100700 |
| 2025 | Cleveland Clinic Foundation Cleveland, OH | C | $331,873 | paid | DEVELOPMENT OF NEW DRUG FOR | 202600389349100700 |
| 2025 | Board Regents of University of Wisconsin Milwaukee, WI | U | $330,487 | paid | IMPROVE DIAGNOSIS OF BREAST | 202600389349100700 |
| 2025 | Medical College of Wisconsin Milwaukee, WI | B | $315,981 | paid | NEW DRUGS TO TREAT | 202600389349100700 |
| 2025 | Universityof Minnesota Minneapolis, MN | U | $308,897 | paid | T3 THERAPY - HEART FAILURE | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $284,681 | paid | OPTIMIZED MECHANISM BASED | 202600389349100700 |
| 2025 | University of Chicago Chicago, IL | C | $268,735 | paid | METASTIC LUNG CANCER PHASE | 202600389349100700 |
| 2025 | Purdue University West Lafayette, IN | B | $257,044 | paid | ADVANCING MICRO RNAS AS | 202600389349100700 |
| 2025 | Northwestern University Evanston, IL | B | $210,398 | paid | THERAPY FOR CHRONIC KIDNEY | 202600389349100700 |
| 2025 | University of Iowa Iowa City, IA | U | $208,319 | paid | VASCULAR HEALTH TARGETING | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $203,837 | paid | SYSTEMIC BACTEREMIA - HOST | 202600389349100700 |
| 2025 | Cleveland Clinic Foundation Cleveland, OH | C | $186,955 | paid | TREATMENT OF COMPLEX | 202600389349100700 |
| 2025 | Ohio State University Columbus, OH | U | $178,604 | paid | MELANOMA ONSET & RECURRENCE | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $176,327 | paid | DEVELOP IL-15 - MALARIA | 202600389349100700 |
| 2025 | Shirley Ryan Ability Lab Chicago, IL | B | $175,864 | paid | RESTORE DIAPHRAGM - NERVE | 202600389349100700 |
| 2025 | Mayo Clinic Rochester, MN | U | $175,575 | paid | CD-19 TARGETED CAR-MSC19 IN | 202600389349100700 |
| 2025 | Michigan State University East Lansing, MI | U | $175,000 | paid | DEVELOP NEW ODC INHIBITORS | 202600389349100700 |
| 2025 | Loyola University of Chicago Chicago, IL | B | $175,000 | paid | INHIBITORS FOR TRIPLE | 202600389349100700 |
| 2025 | University of Cincinnati Cleveland, OH | B | $175,000 | paid | DEVELOP IMPROVED METHOD OF | 202600389349100700 |
| 2025 | Washington University St Louis, MO | B | $175,000 | paid | STEM CELL DERIVED ISLETS | 202600389349100700 |
| 2025 | Regents of University of Michigan Ann Arbor, MI | D | $175,000 | paid | ANTIBODY CNS DELIVERY AND | 202600389349100700 |
| 2025 | Brown University of Providence Providence, RI | C | $175,000 | paid | REPURPOSING CLOPIDOGREL TO | 202600389349100700 |
| 2025 | Regents of University of Michigan Ann Arbor, MI | D | $175,000 | paid | NEURO-CARDIAC MECHANISMS OF | 202600389349100700 |
| 2025 | Case Western Reserve University Cleveland, OH | U | $175,000 | paid | PHARMA STRATEGY TO TREAT | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $173,839 | paid | SOUND WAVES ASSESSMENT VIA | 202600389349100700 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $173,769 | paid | AUTOIMMUNE ARTHRITIS | 202600389349100700 |
| 2025 | Washington University St Louis, MO | B | $173,717 | paid | VAGUS NERVE STIMULATION - | 202600389349100700 |
| 2025 | Brown University of Providence Providence, RI | C | $173,096 | paid | GENE THERAPY FOR | 202600389349100700 |
| 2025 | Indiana University Bloomington, IN | C | $169,910 | paid | TRAUMATIC BRAIN INJURY | 202600389349100700 |
| 2025 | Northwestern University Evanston, IL | B | $168,188 | paid | ANTIBODIES TREATMENT OF | 202600389349100700 |
| 2025 | Yale University - School of Medicine New Haven, CT | U | $161,487 | paid | ANTI VB2 ANTIBODY DRUG FOR | 202600389349100700 |
| 2025 | Ohio State University Columbus, OH | U | $151,908 | paid | DEVELOP NEW THERAPY FOR | 202600389349100700 |
| 2025 | University of Minnesota Minneapolis, MN | U | $150,426 | paid | SEVERITY MEASURE- ADDUCTOR | 202600389349100700 |
| 2025 | Indiana University Bloomington, IN | C | $57,018 | paid | INHIBITORS-PEANUT SPECIFIC | 202600389349100700 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.